Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Share News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.35
Bid: 6.20
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.30 (4.839%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.35
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Sportech, Silverdell, Oxford BioMedica

Fri, 11th May 2012 12:35

Brooks Pierce, the Executive Director of Sportech, has resigned with immediate effect to 'pursue other business interests'. No replacement has yet been appointed, but the company was keen to announce that it had appointed an executive search business to 'seek suitable candidates to further augment Sportech's Executive Directors in order to take advantage of the many opportunities available in North America'.Specialist environmental support services group Silverdell has been awarded a number of contracts in May totalling £3.58m, including a contract in Canada from an international specialist material company. The Canadian contract will deliver £1.25m of revenues in the second half of the current financial year and is an "important step" in the company's broader strategic initiative to penetrate a number of regulated international markets," the firm said. The company also reported that a previously announced rail contract worth £0.5m is likely to be materially higher in value and is now anticipated to form part of a larger framework contract to include up to 72 stations over the next seven years.Oxford BioMedica has said it is very encouraged by the first clinical results of its RentinoStat product, which indicate sustained therapeutic protein expression in the eye. The company is now awaiting further data from its ocular programmes later this year. The firm has also been encouraged by progress at its proprietary manufacturing facility which is set to be fully-operational in the second half of this year, while developments by global drugs giant Pfizer with its 5T4-targeted antibody programme bring it a step closer to clinical trials, at which stage Pfizer would make its next milestone payment to Oxford BioMedica. Braveheart Investment Group, which specialises in venture capital investments, has raised £164,000 after placing over one million new ordinary shares at 15p per share. The new subscription shares will represent around 4.8% of the issued share capital of the company as enlarged by the subscription. The proceeds of the subscription will be used for general working capital, the firm said. Planet Payment has posted a 22% rise in net revenue to $11.7m (2011 $9.6m) for the first quarter, although income remained stable at $0.8m. Income from operations rose from $0.3m to $0.9m. The company said the growth in revenue reflects the increase in transaction processing volumes, primarily driven by increases in active merchant locations. Adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) for the period increased 75% to $1.7m (2011: $1.0m). SnackTime, a UK vending business, has admitted that full-year EBITDA before exceptionals will be slightly below expectations, but said revenues will be on track and emphasised that the re-organisation of the company's property portfolio and associated provisions is expected to give rise to an exceptional profit. The firm's cash levels rose during the second half of the year and said that it remains well within its banking covenants. "SnackTime is well placed to weather the current economic conditions and to emerge from the recession in a stronger competitive position," the company said. Educational software supplier RM has said that following a review of its UK operations it has decided to sell a number of its businesses, including ISIS Concepts, the sale of which has now been completed for £205,000. The sale was made to ISIS Concepts Holdings, a new company formed by Nick Topliss, who owned ISIS before it was sold to RM in 2009, and has remained as its Managing Director. Rob Sirs, former Managing Director of RM, is expected to invest in ISIS Concepts Holdings in the near future. In the financial year to date, ISIS has been loss-making. RM has agreed to provide a short-term working capital loan facility of up to £850,000, secured on freehold property and other assets valued in excess of that figure.
More News
6 Mar 2024 14:14

IN BRIEF: Braveheart buys 4 million Autins shares for GBP320,000

Braveheart Investment Group PLC - Dodworth, England-based investment company - Between Monday and Tuesday, buys a further 4.0 million shares in Autins Group PLC at an average price of 8 pence per share, for a total of GBP320,000. Following this, now holds 23% of the issued share capital of Autins.

Read more
6 Mar 2024 13:56

Braveheart takes Autins stake to over 23pc

(Sharecast News) - Braveheart Investment Group announced a significant increase in its ownership stake in Autins Group on Wednesday.

Read more
4 Mar 2024 19:59

TRADING UPDATES: Beowulf raises funds for Kallak iron ore project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
4 Mar 2024 14:47

Braveheart to retain Paraytec after failing to find buyer

(Sharecast News) - Braveheart Investment Group updated the market on one of its key investments, Paraytec, on Monday, confirming that it had failed to find an appropriate buyer for the company.

Read more
4 Mar 2024 14:29

TRADING UPDATES: Beowulf ups Vardar stake; Impellam buyout nears

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
22 Dec 2023 14:26

IN BRIEF: Braveheart Investment to sell Phasefocus for GBP5 million

Braveheart Investment Group PLC - Dodworth, England-based investment company - Announces conditional sale of Phasefocus Holdings Ltd to analytics instrumentation company Bruker UK Ltd for GBP5 million. Once closing conditions are satisfied, Braveheart expects completion of the sale to occur in the first quarter of 2024. Consideration will be payable in cash and represent GBP17.74 per Phasefocus share. Braveheart currently holds 48.3% of Phasefocus's issued share capital. Estimates that it will receive total sale proceeds of approximately GBP2.1 million after expenses. Braveheart says board is still considering whether to use proceeds to continue support further investments in technology-based companies, or whether to redistribute the proceeds via a special dividend.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
14 Dec 2023 17:20

EARNINGS AND TRADING: abrdn Diversified Income to begin wind-down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Nov 2023 16:32

Braveheart Investment firm gets first CX300 detector sales contract

(Alliance News) - Braveheart Investment Group PLC on Wednesday said its wholly-owned portfolio company Paraytec Ltd has secured its first commercial sales contract for the CX300 Optical Particle detector instrument.

Read more
17 Oct 2023 17:03

IN BRIEF: Braveheart Investment investee Paraytec updates on CX300

Braveheart Investment Group PLC - Dodworth, England-based investment company - Investee company Paraytec Ltd updates on its work in the development of potential use cases for its rapid test instrument, CX300. Explains it has been successfully tested in the detection of adeno-associated viruses, which are used in gene therapy. Notes this is important because virus-like particles such as adeno-associated viruses are used to encapsulate the new gene and deliver it into the body. Points out the target is to market the CX300 for use by all gene therapy manufacturers for in-process assessment of the quality of their adeno-associated virus products during research, development and, in due course, manufacturing.

Read more
8 Sep 2023 14:07

Braveheart upbeat on investee's brain research breakthrough

(Sharecast News) - Braveheart Investment Group updated the market on the progress of its investee company Kirkstall on Friday, including a recent breakthrough in the study of the human blood-brain barrier and its interaction with brain cancer.

Read more
8 Sep 2023 11:42

IN BRIEF: Braveheart Investment investee Kirkstall develops new model

Braveheart Investment Group PLC - Dodworth, England-based investment company - Updates on Kirkstall Ltd, a company within its investment portfolio. Says Kirkstall, in conjunction with the Biomedical Ultrasonics, Biotherapy & Biopharmaceutical Laboratory within the Institute of Biomedical Engineering at the University of Oxford, has developed an "organ on a chip" model of a milli-fluidic system, human blood-brain barrier which has been used to map the interaction between the blood-brain barrier and brain cancer. Explains this is the first time a dynamic milli-fluidic model has been developed where the interactions between the blood-brain barrier and medulloblastoma brain cancer spheroids have been demonstrated.

Read more
21 Aug 2023 10:14

Braveheart invests GBP150,000 in Phasefocus for cancer-focused assay

(Alliance News) - Braveheart Investment Group PLC on Monday said it has invested more in Phasefocus Holdings Ltd, a Sheffield-based company that develops products that quantify and compare dynamic live cell behaviour.

Read more
28 Jul 2023 20:46

TRADING UPDATES: Limitless Earth loss widens; Black Sea NAV rises

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
21 Jul 2023 15:38

UK shareholder meetings calendar - next 7 days

Monday 24 July 
Barryroe Offshore Energy PLCEGM re proposed cancellation of admission to trading on AIM
Cranswick PLCAGM
discoverIE Group PLCAGM
MobilityOne LtdAGM
Plus500 LtdEGM to authorise share re-purchase
TClarke PLCGM re necessary resolutions to shareholders for placing of new ordinary shares
WANdisco PLCGM re increase of share capital
Tuesday 25 July 
ADM Energy PLCAGM
Atome Energy PLCAGM
B&M European Value Retail SAAGM
GlobalData PLCGM re capital reorganisation
JZ Capital Partners LtdAGM
MITIE Group PLCAGM
Molecular Energies PLCAGM
Polymetal International PLCAGM
Safestay PLCAGM
Verditek PLCAGM
Vodafone Group PLCAGM
Wednesday 26 July 
Aquila Services Group PLCAGM
Blackstone Loan Financing LtdAGM
BP Marsh & Partners PLCAGM
Eurasia Mining PLCAGM
Molten VenturesAGM
Motorpoint Group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC and LtdAGM
Norcros PLCAGM
Oracle Power PLCAGM
Palace Capital PLCAGM
ProBiotix Health PLCAGM
Seeen PLCAGM
Silverwood Brands PLCAGM
Triad Group PLCAGM
Water Intelligence PLCAGM
Zephyr Energy PLCAGM
Thursday 27 July 
Foresight Group Holdings LtdAGM
Marks Electrical Group PLCAGM
Silver Bullet Data Services Group PLCAGM
Friday 28 July 
African Pioneer PLCAGM
Bezant Resources PLCAGM
Braveheart Investment Group PLCAGM
Cordiant Digital Infrastructure LtdAGM
DP Poland PLCAGM
Intuitive Investments Group PLCGM re proposals on investment strategy
Jangada Mines PLCAGM
Mercantile Ports & Logistics LtdAGM
MetalNRG PLCAGM
Northern 2 VCT PLCGM re party transaction
Polymetal International PLCGM re delisting
R&Q Insurance Holdings LtdAGM
Science in Sport PLCAGM
Urban Logistics REIT PLCAGM
Xtract Resources PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.